ResearcherGerman Cancer Research CenterActive in the last 2 years
Andrea Mairani
Matched on ORCID iD 0000-0001-6669-7064; OpenAlex author ID A5105788696, A5112472316. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 18
2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper
Papers 6
- Carbon ion radiotherapy for non-metastatic pancreatic cancer: final results of the prospective phase 2 PACK-study (NCT04194268). Co-author DOI 10.1016/j.radonc.2026.111836↗
- Investigating LETd optimization strategies in carbon ion radiotherapy for pancreatic cancer: a dosimetric study using an anthropomorphic phantom. Last author DOI 10.1002/mp.17569↗
- First in vitro and in vivo experiments with ultra high-dose rate oxygen ion radiotherapy Co-author DOI 10.1016/j.phro.2025.100803↗
- Evaluation of Helium Ion Radiotherapy in Combination with Gemcitabine in Pancreatic Cancer In Vitro. Co-author DOI 10.3390/cancers16081497↗
- Carbon-ion radiotherapy (CIRT) as treatment of pancreatic cancer at HIT: initial radiation plan analysis of the prospective phase II PACK-study. Last author DOI 10.1016/j.radonc.2023.109872↗
- In vitro evaluation of photon and raster-scanned carbon ion radiotherapy in combination with gemcitabine in pancreatic cancer cell lines. Co-author DOI 10.1093/jrr/rrt052↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jürgen Debus · 5 shared papers, 2013–2026 · strength 0.95
- Paper Investigating LETd optimization strategies in carbon ion radiotherapy for pancreatic cancer: a dosimetric study using a… DOI 10.1002/mp.17569↗
- Paper Carbon ion radiotherapy for non-metastatic pancreatic cancer: final results of the prospective phase 2 PACK-study (NCT0… DOI 10.1016/j.radonc.2026.111836↗
- Paper Evaluation of Helium Ion Radiotherapy in Combination with Gemcitabine in Pancreatic Cancer In Vitro. DOI 10.3390/cancers16081497↗
- Jakob Liermann · 4 shared papers, 2023–2026 · strength 0.88
- Paper Investigating LETd optimization strategies in carbon ion radiotherapy for pancreatic cancer: a dosimetric study using a… DOI 10.1002/mp.17569↗
- Paper Carbon ion radiotherapy for non-metastatic pancreatic cancer: final results of the prospective phase 2 PACK-study (NCT0… DOI 10.1016/j.radonc.2026.111836↗
- Paper Evaluation of Helium Ion Radiotherapy in Combination with Gemcitabine in Pancreatic Cancer In Vitro. DOI 10.3390/cancers16081497↗
- Filipa Baltazar · 3 shared papers, 2023–2026 · strength 0.67
- Paper Investigating LETd optimization strategies in carbon ion radiotherapy for pancreatic cancer: a dosimetric study using a… DOI 10.1002/mp.17569↗
- Paper Carbon ion radiotherapy for non-metastatic pancreatic cancer: final results of the prospective phase 2 PACK-study (NCT0… DOI 10.1016/j.radonc.2026.111836↗
- Paper Carbon-ion radiotherapy (CIRT) as treatment of pancreatic cancer at HIT: initial radiation plan analysis of the prospec… DOI 10.1016/j.radonc.2023.109872↗
- Klaus K Herfarth · 3 shared papers, 2023–2026 · strength 0.61
- Paper Carbon ion radiotherapy for non-metastatic pancreatic cancer: final results of the prospective phase 2 PACK-study (NCT0… DOI 10.1016/j.radonc.2026.111836↗
- Paper Evaluation of Helium Ion Radiotherapy in Combination with Gemcitabine in Pancreatic Cancer In Vitro. DOI 10.3390/cancers16081497↗
- Paper Carbon-ion radiotherapy (CIRT) as treatment of pancreatic cancer at HIT: initial radiation plan analysis of the prospec… DOI 10.1016/j.radonc.2023.109872↗
- Ivana Đokić · 2 shared papers, 2024–2025 · strength 0.42
- Christina Stengl · 1 shared paper, 2025 · strength 0.27
- Christoph Michalski · 1 shared paper, 2026 · strength 0.23
- Manuel Röhrich · 1 shared paper, 2026 · strength 0.23
- Patrick Naumann · 1 shared paper, 2026 · strength 0.23
- Semi Harrabi · 1 shared paper, 2026 · strength 0.23
- Christoph Springfeld · 1 shared paper, 2026 · strength 0.23
- Bahar Cepni · 1 shared paper, 2024 · strength 0.21
- Celine Karle · 1 shared paper, 2025 · strength 0.21
- Juergen Debus · 1 shared paper, 2023 · strength 0.18
- Rami Ateyah El Shafie · 1 shared paper, 2013 · strength 0.03
- Stephanie Elisabeth Combs · 1 shared paper, 2013 · strength 0.03
- Stefan Rieken · 1 shared paper, 2013 · strength 0.03
- Daniel Habermehl · 1 shared paper, 2013 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.